RT Journal Article
SR Electronic
T1 Simple quantitative assessment of the outdoor versus indoor airborne transmission of viruses and covid-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.30.20249058
DO 10.1101/2020.12.30.20249058
A1 B.R. Rowe
A1 A. Canosa
A1 J.M. Drouffe
A1 J.B.A. Mitchell
YR 2021
UL http://medrxiv.org/content/early/2021/01/04/2020.12.30.20249058.abstract
AB In this paper we develop a simple model of the inhaled flow rate of aerosol particles of respiratory origin i.e. that have been exhaled by other humans. A connection is made between the exposure dose and the probability of developing an airborne disease. This allows a simple assessment of the outdoor versus indoor risk of contamination to be made in a variety of meteorological situations. It is shown quantitatively that for most cases, the outdoor risk is orders of magnitude less than the indoor risk and that it can become comparable only for extremely specific meteorological and geographical situations. It sheds a light on various observations of Covid-19 spreading in mountain valleys with temperature inversions while at the same time other areas are much less impacted.HighlightsRisk of covid-19 airborne transmission.Quantitative assessment of outdoor versus indoor airborne risk of transmission.Meteorological and geographical influence on covid-19 airborne transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding supportAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no IRB and/or ethics committee approval has been necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesno additional data available